KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.3 billion.

  • GoodRx Holdings' Liabilities and Shareholders Equity fell 216.55% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year decrease of 928.74%. This contributed to the annual value of $1.4 billion for FY2024, which is 1263.43% down from last year.
  • Per GoodRx Holdings' latest filing, its Liabilities and Shareholders Equity stood at $1.3 billion for Q3 2025, which was down 216.55% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Liabilities and Shareholders Equity registered a high of $1.7 billion during Q3 2023, and its lowest value of $1.3 billion during Q1 2025.
  • For the 5-year period, GoodRx Holdings' Liabilities and Shareholders Equity averaged around $1.5 billion, with its median value being $1.6 billion (2022).
  • In the last 5 years, GoodRx Holdings' Liabilities and Shareholders Equity soared by 935.38% in 2021 and then tumbled by 2067.52% in 2024.
  • Quarter analysis of 5 years shows GoodRx Holdings' Liabilities and Shareholders Equity stood at $1.6 billion in 2021, then decreased by 0.19% to $1.6 billion in 2022, then fell by 0.99% to $1.6 billion in 2023, then fell by 12.63% to $1.4 billion in 2024, then fell by 4.51% to $1.3 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.